
Enzene Biosciences
Pune, India enzene.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Enzene Biosciences is a global CDMO and biosimilar developer that provides biologics discovery, development, manufacturing, and supply services. It serves biopharma organizations and other partners from sites in India and the United States, and also offers NeX™ for local biosimilar manufacturing. The company works on accessible, high-quality treatments for patients worldwide.
Services
Target identification and validation
Identifies and validates disease targets using gene/protein expression, cellular signaling, genetic evidence, knockdown studies, pharmacological evidence, and other preclinical approaches.
Antibody discovery and engineering
Discovers and engineers antibodies using hybridoma technology, patient-derived B-cell libraries, AI/ML-generated synthetic libraries, display engineering, affinity maturation, and epitope mapping.
Custom reagents
Provides custom reagents as part of its drug discovery solutions.
Assay development solutions
Develops assay and screening solutions to support drug discovery programs.
Cell line development
Supports cell line development as part of its drug development CDMO offering.
Cell line development
Process development
Develops processes for biologics programs as part of its drug development services.
Formulation development
Develops formulations as part of its biologics development services.
Analytical methods
Develops analytical methods to support development and characterization work.
11 more services
- Product characterization
- Dynamic process screening
- Bioassay capability
- Stability studies
- Tech transfer and scale-up
- Drug substance manufacturing
- Drug product manufacturing
- Quality assurance and control
- Regulatory affairs
- Biosimilarity packages
- AAV technology
- Minimums and prices
- Making $40/gram possible
Capabilities
- Assays and studies
- Antibodies
- AAV
- Stability studies
- Process development
- Bispecifics
- Target identification
11 more
- Target validation
- Screening
- Gene/protein expression analysis
- Cellular signaling pathway analysis
- Knockdown studies
- Pharmacological evidence studies
- Preclinical studies
- Druggability assessment
- Clinical human POC
- Affinity maturation
- Epitope mapping
- Scale and capacity
- Minimum 30-50L supply
- Six drug substance manufacturing suites
- Therapeutic areas
- Cancer
- Autoimmune disorders
- Infections
Instruments and platforms
- X-ray crystallography
- Cryo-EM
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Viral vector
- Biosimilar
- Species and models
- Patient-derived B-cell libraries
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO 14001:2015Self-reported
GMPSelf-reported
ISO 45001:2018Self-reported
ISO 13485:2016Self-reported
Scope: unit I
Details
- Type
- CRDMO
- Office
- 311 Pennington Rocky Hill Road, Building 21 Pennington, NJ 08534
- Sites
- Pennington, NJ, United States
- Serves
- India, United States, global